TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ACET

Adicet Bio Inc

Healthcare · Biotechnology

6.50$ -2.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Adicet Bio Inc (ACET) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 148 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACET
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
545 1,045 1,059 1,038 1,018 55 137 129 117 110 145 137 122 82 78 74 150 154 282 269 257 339 340 330 354 331 305 278 233 207 293 269 246 220 191 163 140 192 169 148
356 459 481 472 468 55 137 128 117 110 25 136 121 64 78 74 117 100 229 216 199 282 282 264 286 261 235 209 186 162 250 228 206 180 154 128 106 161 140 121
73 68 60 56 72 53 136 51 23 7.0 -25 21 24 11 61 71 85 84 222 209 192 278 278 261 283 258 232 205 183 160 248 224 105 56 28 35 29 39 36 33
75 70 62 58 – 53 136 126 115 108 25 133 117 62 76 71 108 95 223 209 192 278 278 261 283 258 232 205 183 160 248 224 202 176 150 125 103 159 138 118
159 224 261 261 241 242 260 247 292 262 – – – 0.9 0.9 10 3.5 2.7 2.8 2.7 2.7 0.2 0.0 0.0 0.0 0.4 0.6 0.6 0.0 – – – 0.2 – – – 0.2 0.3 0.4 0.4
104 145 140 136 135 148 142 137 157 184 – – – 0.7 – 0.0 5.8 -3.1 2.8 4.5 4.1 0.0 – – -0.3 2.6 2.1 2.1 2.2 – – – – – – – – – – –
10 9.9 10 10 12 13 14 14 14 – – – – 0.4 2.0 1.8 2.0 26 26 26 32 35 37 45 48 49 – 49 46 – – – – – – – – – – –
68 241 242 237 237 237 1.9 1.9 1.9 1.9 – – – 0.0 – – 21 20 20 19 19 19 19 19 19 19 19 19 0.0 0.0 – – – – – – – – – –
78 301 293 285 277 270 242 235 228 221 – – – – – – 3.5 1.2 0.7 – – – – – – – – – – – – – – – – – – – – –
235 648 656 633 609 5.5 6.9 12 8.1 5.7 4.6 9.7 12 142 2.6 3.6 33 44 46 40 40 36 29 37 37 38 39 39 39 37 34 34 34 34 30 30 31 33 29 28
93 208 232 223 227 5.5 6.8 12 8.1 5.7 4.6 9.7 12 15 2.6 3.6 30 22 25 21 20 16 10 16 17 20 18 19 20 19 17 18 19 19 16 17 19 22 18 18
0.2 14 14 14 14 14 191 14 14 184 – – – – – – 23 1.2 1.2 1.1 0.7 1.6 1.7 2.3 2.4 2.5 2.9 3.0 3.1 3.2 3.3 3.4 3.3 3.1 3.0 3.0 3.3 3.2 2.9 2.8
49 90 111 90 98 107 125 107 123 – 3.4 8.2 10.0 1.1 1.2 2.5 3.8 1.6 1.7 2.3 4.6 3.3 3.5 4.1 4.6 4.4 2.7 3.1 4.1 2.6 2.5 1.9 2.5 4.8 4.4 3.3 4.3 4.7 2.9 3.6
120 368 353 339 317 312 129 303 301 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
310 396 402 405 409 -32 130 117 109 104 4.6 127 110 -60 76 71 117 110 236 228 217 303 311 293 318 292 266 239 195 170 259 235 212 187 161 133 109 159 140 120
197 195 198 196 194 -34 -44 -57 -66 -71 -82 -101 -125 -70 -161 -167 -97 -106 -128 -138 -153 -168 -164 -186 -208 -238 -269 -301 -351 -381 -409 -439 -469 -498 -526 -557 -584 -615 -635 -656
1.6 1.6 1.7 1.6 1.7 40 1.2 1.5 1.5 26 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.6 2.0 2.0 2.1 2.9 2.5 2.6 2.6 2.7 2.7 2.7 2.7 4.9 5.7 5.7 5.5 5.7 5.7 5.7 6.9 11 11

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?